Mathieu Gabut

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Nature communications

Cancers

Neuro-oncology advances

Cells

INSERM

Institut de Génétique Moléculaire Montpellier (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM

France

Researcher and Principal Investigator

Ontario Institute for Cancer Research

Canada

Research Associate :: Genomics

Education History

Institut de Génétique Moléculaire Montpellier

France

PHD

École normale supérieure de Lyon

France

MSC

École normale supérieure de Lyon

France

BSC

Publications

Sébastien Durand, Marion Bruelle, Fleur Bourdelais, Bigitha Bennychen, Juliana Blin, Caroline Isaac, Aurélia Huyghe, Sylvie Martel, Antoine Seyve, Christophe Vanbelle, Annie Adrait, Yohann Cout, David Meyronet, Frédéric Catez, Jean-Jacques Diaz, Fabrice Lavial, Emiliano P Ricci, François Ducray, Mathieu Gabut
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells. Nature communications 14 (1) (2023)
Sébastien Durand, Marion Bruelle, Fleur Bourdelais, Bigitha Bennychen, Juliana Blin, Caroline Isaac, Aurélia Huyghe, Sylvie Martel, Antoine Seyve, Christophe Vanbelle, Annie Adrait, Yohann Cout, David Meyronet, Frédéric Catez, Jean-Jacques Diaz, Fabrice Lavial, Emiliano P Ricci, François Ducray, Mathieu Gabut
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells. Nature communications 14 (1) (2023)
Sébastien Durand, Marion Bruelle, Fleur Bourdelais, Bigitha Bennychen, Juliana Blin, Caroline Isaac, Aurélia Huyghe, Sylvie Martel, Antoine Seyve, Christophe Vanbelle, Annie Adrait, Yohann Cout, David Meyronet, Frédéric Catez, Jean-Jacques Diaz, Fabrice Lavial, Emiliano P Ricci, François Ducray, Mathieu Gabut
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells. Nature communications 14 (1) (2023)
Laurent Turchi, Nathalie Sakakini, Gaelle Saviane, Béatrice Polo, Mirca Saras Saurty-Seerunghen, Mathieu Gabut, Corine Auge Gouillou, Vincent Guerlais, Claude Pasquier, Marie Luce Vignais, Fabien Almairac, Hervé Chneiweiss, Marie-Pierre Junier, Fanny Burel-Vandenbos, Thierry Virolle
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 15 (20) (2023)
Thiebaud Picart, Marc Barritault, Delphine Poncet, Lise-Prune Berner, Cristina Izquierdo, Emeline Tabouret, Dominique Figarella Branger, Ahmed Idbaïh, Franck Bielle, Véronique Bourg, Fanny Burel Vandenbos, Elizabeth Cohen-Jonathan Moyal, Emmanuelle Uro-Coste, Jacques Guyotat, Jérôme Honnorat, Mathieu Gabut, David Meyronet, François Ducray
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neuro-oncology advances 3 (1) (2021)
Mariam Jaafar, Hermes Paraqindes, Mathieu Gabut, Jean-Jacques Diaz, Virginie Marcel, Sébastien Durand
2'O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases. Cells 10 (8) (2021)
Deborah Fanfone, Ahmed Idbaïh, Jade Mammi, Mathieu Gabut, Gabriel Ichim
Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres. Cancers 12 (10) (2020)

Mathieu Gabut.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mathieu Gabut